2022
Filter by Topic
17-Nov-22
Capital Markets Event
Corporate10-Nov-22
Convatec Group Plc Trading update for the ten months ended 31 October 2022
Corporate Financial Performance04-Aug-22
Interim Results for the six months ended 30 June 2022
Corporate Financial Performance18-May-22
New survey finds 87% of patients with long-term health conditions face stigma; nurses feel they lack time and resources to provide adequate support
Corporate12-May-22
AGM trading update for the four months ended 30 April 2022
Corporate Financial Performance09-May-22
Convatec invests in BlueWind Medical to fund development of innovative neuromodulation technology
Corporate Continence Care14-Mar-22
Convatec Group completes acquisition of Triad Life Sciences Inc as it enters attractive wound biologics segment1
Corporate Advanced Wound Care08-Mar-22
Annual Results for the twelve months ended 31 December 2021
Corporate Financial Performance28-Feb-22
Non-Executive Directors - Appointment and Resignation
Corporate Our People28-Jan-22
Entry into the attractive wound biologics segment through the acquisition of Triad Life Sciences Inc
Corporate Advanced Wound Care27-Jan-22
Board Committee Changes
Corporate Our PeopleLearn more about the medical solutions we offer
Contact the media team